BSX
Boston Scientific CorporationHealthcare · $64.6B market cap
Verdict
Share price
$42.60
close of Oct 3, 2026
Fair value
$44.42
Sticker Price
Payback Price
$17.77
buy price
BSX is Fairly Valued: at $42.60 it's within 4% of its fair value of $44.42. Its buy price (Payback Price) is $17.77, 58% below today's price. Business quality is limited: only 1 of 5 key numbers clears the 10% bar.
How we valued it
Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.
Business quality
1 of 5 clear the 10% bar. What are the Big Five?
Follow BSX
Get notified when it reaches its buy price of $17.77. Free.
Create a free accountSuperinvestors
5 of the investors we track hold BSX. In Q2 2026, 1 opened a position, 1 added, 1 trimmed and 1 sold out. Who we track
Lee Ainslie
Maverick Capital · as of Q2 2026
$253.4M
5,937,553 shares
Sarah Ketterer
Causeway Capital Management · as of Q2 2026
$30.7M
720,339 shares
Dodge & Cox Funds
Dodge & Cox Funds · as of Q2 2026
$3.7M
87,485 shares
Mairs & Power Funds
Mairs & Power Funds · as of Q2 2026
$423K
9,914 shares
Polen Capital Management
Polen Capital Management · as of Q2 2026
$203K
4,750 shares
Moves in Q2 2026
New position: Sarah Ketterer
Added: Lee Ainslie
Trimmed: Polen Capital Management
Sold out: Stephen Mandel
Insider activity
Since Jul 1, 2026: 6 open-market purchases worth $9.5M and 8 other filings (stock awards, tax withholding and similar). Why purchases matter
Purchases
Morano Susan E
director · 2026-08-25
Bought
$100K
Habiger David C
director · 2026-08-05
Bought
$100K
Habiger David C
director · 2026-08-04
Bought
$7K
Mahoney Michael F
Chairman, President & CEO · 2026-08-03
Bought
$9.0M
Habiger David C
director · 2026-08-03
Bought
$50K
LUDWIG EDWARD J
director · 2026-07-31
Bought
$227K
Other filings
O'Connor Padraig Andrew
EVP, Global Operations · 2026-09-02
Tax withholding
$27K
O'Connor Padraig Andrew
EVP, Global Operations · 2026-09-02
Option exercise
1,171 shares
Woodworth Emily
SVP, Global Controller and CAO · 2026-08-11
I-Discretionary
$150K
Monson Jonathan
EVP and CFO · 2026-08-10
I-Discretionary
$500K
Mahoney Michael F
Chairman, President & CEO · 2026-08-03
I-Discretionary
$1.1M
About Boston Scientific Corporation
Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the…
Medical - Devices
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works